Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

3 years ago 293

Moderna shares plunged 12.3% successful premarket trading connected Thursday aft income of the company’s Covid-19 vaccine fell abbreviated of Wall Street analysts’ estimates by much than a cardinal dollars.

The institution reported full gross of $5 cardinal for the 3rd 4th of the year, 20% abbreviated of the FactSet expert statement estimation of $6.2 billion. Spikevax, Moderna‘s (ticker: MRNA) Covid-19 vaccine, is the company’s lone product.

The...

Read Entire Article

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Related

How To Unlock New Collaborations through Guest Blog Contribu...

Stock market news live updates: Stock futures rise after Nas...

Ford to book $8.2 billion fourth-quarter profit on Rivian in...

Good News for Retirees: RMD Formula Changing for First Time ...

Trending

Popular

Try on LeBron's jersey with 3D shopping experience built by ...

Insulin Isn't the Only Blood Sugar Regulator

Is Sony expanding PS5 backward compatibility?

Bob Saget's wife Kelly Rizzo shares an emotional tribute to ...

'I'm just so embarrassed': Bono really isn't U2's biggest fa...